Trial Profile
Named Patient Use Program to Provide Abemaciclib for the Treatment of Metastatic Breast Cancer
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 16 Oct 2023
Price :
$35
*
At a glance
- Drugs Abemaciclib (Primary)
- Indications Advanced breast cancer
- Focus Expanded access; Therapeutic Use
- Sponsors Eli Lilly and Company
- 12 Dec 2018 New trial record